The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
iShares US Healthcare ETF IYH
- NAV / 1-Day Return 61.90 / +1.33 %
- Total Assets 3.5 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.400%
- Distribution Fee Level —
- Share Class Type —
- Category Health
- Investment Style Large Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 1.11%
- Turnover 3%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 1:00 AM GMT+0
Morningstar’s Analysis IYH
Will IYH outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 53.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 11.78 | 407.5 Mil | Healthcare |
UnitedHealth Group Inc | 8.13 | 281.3 Mil | Healthcare |
Johnson & Johnson | 6.73 | 233.0 Mil | Healthcare |
Merck & Co Inc | 5.73 | 198.2 Mil | Healthcare |
AbbVie Inc | 5.67 | 196.2 Mil | Healthcare |
Thermo Fisher Scientific Inc | 3.98 | 137.8 Mil | Healthcare |
Abbott Laboratories | 3.43 | 118.6 Mil | Healthcare |
Danaher Corp | 2.94 | 101.6 Mil | Healthcare |
Pfizer Inc | 2.79 | 96.5 Mil | Healthcare |
Amgen Inc | 2.70 | 93.4 Mil | Healthcare |